Lv3
380 积分 2023-05-14 加入
Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment
1天前
待确认
Prognosis of Patients With Early Breast Cancer Receiving 5 Years vs 2 Years of Adjuvant Bisphosphonate Treatment
1天前
已完结
Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial
1天前
已完结
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
1天前
已完结
Denosumab for treatment of breast cancer bone metastases and beyond
1天前
已完结
Differences between zoledronic acid and denosumab for breast cancer treatment
1天前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2天前
已完结
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectives
3天前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
4天前
已完结
Thrombopoietic Agents for the Treatment of Persistent and Chronic Immune Thrombocytopenia in Children
7天前
已完结
皖公网安备34019202002308
